Badial Verender S. 5
5 · Zura Bio Ltd · Filed Feb 14, 2025
Insider Transaction Report
Form 5
Zura Bio LtdZURA
Badial Verender S.
Chief Financial Officer
Transactions
- Other
Warrants
2023-09-28+420,519→ 0 totalExercise: $11.50From: 2023-04-19Exp: 2028-03-20→ Class A Ordinary Shares (420,519 underlying) - Disposition to Issuer
Warrants
2024-08-23−420,519→ 0 totalExercise: $11.50From: 2023-04-19Exp: 2028-03-20→ Class A Ordinary Shares (420,519 underlying) - Other
Class A Ordinary Shares
2023-09-22+35,484→ 517,519 total - Other
Class A Ordinary Shares
2023-09-28+355,880→ 517,519 total - Award
Class A Ordinary Shares
2024-08-23+126,155→ 517,519 total
Footnotes (3)
- [F1]The Class A ordinary shares were distributed by JATT Ventures L.P. ("JATT") to the Reporting Person for no additional consideration.
- [F2]The reported warrants were exchanged for Class A Ordinary Shares ("Ordinary Shares") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference.
- [F3]The warrants were distributed by JATT to the Reporting Person for no additional consideration.